In this study, AG, mangiferin, and hederagenin inhibited the NF-κB signaling pathway, and THJ, TCT, and formononetin inhibited the NLRP3 signaling pathway to reduce the inflammatory response of DCM. This evidence concerns the gene NFKB1 and familial dilated cardiomyopathy.